HRYZ Biotech Co.

Quick facts

Phase 3 pipeline

• PD1 antibody · Oncology
  PD1 antibody works by binding to the PD-1 receptor on T cells, blocking its interaction with PD-L1 and allowing the immune system to attack cancer cells.

Phase 2 pipeline

• MASCT-I

Phase 1 pipeline

• HRYZ-T101 TCR-T Cell

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• HRYZ Biotech Co. portfolio CI brief
• HRYZ Biotech Co. pipeline updates RSS